Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
BioNTech SE
BioNTech SE
M.D. Anderson Cancer Center
BeOne Medicines
M.D. Anderson Cancer Center
Danish Gynecological Cancer Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Seagen Inc.
National Cancer Institute (NCI)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
MedSIR
Duke University
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
CanariaBio Inc.
City of Hope Medical Center
Arcus Biosciences, Inc.
AstraZeneca
University of Iowa
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Akeso
Gilead Sciences
National Medical Research Radiological Centre of the Ministry of Health of Russia
BioNTech SE
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
Hoffmann-La Roche
Ohio State University Comprehensive Cancer Center
ETOP IBCSG Partners Foundation
AstraZeneca
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Institute of Cancer Research, United Kingdom
Wake Forest University Health Sciences
TJ Biopharma Co., Ltd.
Montefiore Medical Center
Klus Pharma Inc.
Dana-Farber Cancer Institute
Swiss Cancer Institute
Imperial College London